102 related articles for article (PubMed ID: 15236793)
1. Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease.
Shen ZX
Med Hypotheses; 2004; 63(2):285-97. PubMed ID: 15236793
[TBL] [Abstract][Full Text] [Related]
2. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease.
Shen ZX
Med Hypotheses; 2004; 63(2):308-21. PubMed ID: 15236795
[TBL] [Abstract][Full Text] [Related]
3. Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
Shen ZX
Med Hypotheses; 2004; 63(2):298-307. PubMed ID: 15236794
[TBL] [Abstract][Full Text] [Related]
4. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
5. Rationale for diagnosing deficiency of ChEs and for applying exogenous HuChEs to the treatment of diseases.
Shen ZX
Med Hypotheses; 2008; 70(1):43-51. PubMed ID: 17587508
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
Mesulam MM; Asuncion Morán M
Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
9. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
11. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
12. Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete.
MacDonald AB
Med Hypotheses; 2006; 67(3):592-600. PubMed ID: 16675154
[TBL] [Abstract][Full Text] [Related]
13. [Neuromodulators and Alzheimer's disease].
Vallet PG; Bouras C
Encephale; 1988; 14(5):345-51. PubMed ID: 2463900
[TBL] [Abstract][Full Text] [Related]
14. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.
Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY
Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746
[TBL] [Abstract][Full Text] [Related]
15. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
17. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
Jeynes B; Provias J
Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
[TBL] [Abstract][Full Text] [Related]
18. [Histopathology of Alzheimer's disease].
Yardin C
Morphologie; 2007 Dec; 91(295):199-201. PubMed ID: 18024114
[TBL] [Abstract][Full Text] [Related]
19. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
Suzuki T; Araki Y; Yamamoto T; Nakaya T
J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
[TBL] [Abstract][Full Text] [Related]
20. Pathological correlates of cognitive decline in Alzheimer's disease.
Thind K; Sabbagh MN
Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
